"The Committee does not expect it will be appropriate to reduce the...
Category:
Eco/Invest/Demography
Latest
Middle class,internet connectivity propelled e-commerce market Economy Review
India's e-commerce market is expected to reach $163 billion by...
Thalassemia, haemophilia patients in Haryana to get Rs 3,000 monthly disability pension
Manohar Lal Khattar, Chief Minister,Haryana Last year, Haryana...
Paytm and Vijay Sharma acquire Raheja QBE general insurance for Rs 568 crore,QBE exits Indian market
“It is an important milestone in Paytm’s financial services journey, and we are very excited to welcome Raheja QBE General Insurance into the Paytm family. Its strong management team will help us accelerate our journey of taking insurance to the large population of India with the aim to create a tech-driven, multi-channel general insurance company with innovative and affordable insurance products,” said Paytm president Amit Nayyar
India’s COVID-19 cases close to 7-lakh mark,tests cross one-crore mark
A single-day jump of 24,248 COVID-19 cases took India’s tally close to the 7-lakh mark on Monday, while the death toll due to the disease climbed to 19,693 with 425 new fatalities, according to the Union Health Ministry,
India is now the world’s third worst-affected country, behind only the United States and Brazil.It has seen eight times the number of cases as China, that has a similar-sized population and is where the virus originated late last year.
“A cumulative total of 1,00,04,101 samples have been tested till 11 am on Monday with 1,80,596 samples being tested on July 5,” Scientist and media coordinator at the Indian Council of Medical Research (ICMR), Dr Lokesh Sharma said
.
GI Council unveils rate chart for Covid-19 tretments in hospitals,caps it at Rs18k for ICU with ventilator
These rates will be applicable to both cashless and reimbursement Covid-19 claims in States/Union territories/Cities where any Government Authority has not published standard charges for Covid-19 treatment.
Mylan to launch generic remdesivir version in India at $64 per 100 mg vial
Remdesivir is in high demand after the intravenously-administered medicine helped to shorten hospital recovery times in a clinical trial. On Friday, it got conditional approval from the European Commission for use in severe COVID-19 patients.
Govt may appoint ecommerce regulator; impose stricter rules on Google, Amazon: Report
The suggested norms may mandate that online companies provide the government access to their source codes and algorithms, the report said.
BOCI writes to IRDAI for extension of vehicle insurance validity
Owners pay about Rs 1 lakh per year towards insurance premium for a bus, and for premium buses it might go up to Rs 2 lakh, he added.
The vehicles have been grounded since lockdown, therefore third-party damage is ruled out. Since a major part of the premium amount is paid towards third-party damage, the insurance companies should increase validity equal to the number of lockdown days, BOCI said.
Panel probing deadly south Indian gas leak finds LG Polymers negligent
“There were no proper preventive mechanisms to avert such incidents and the warning siren facility was also not in order,” the Andhra Pradesh government statement on the committee’s findings said
Eco package,opening up of economy post lock down have begun showing results: Survey
The Ficci-Dhruva Advisors industry survey was conducted in June 2020 and saw participation of over 100 top corporate executives (CxOs) from across sectors.
“While the green shoots of recovery are being seen, it is important to emphasise that sustaining this improvement in the operational parameters of businesses will require continuous support from the government.
Chinese city sounds alert for Bubonic Plague amid second wave Of Covid-19
Bubonic plague is a bacterial disease that is spread by fleas living on wild rodents such as marmots. It can kill an adult in less than 24 hours if not treated in time, according to the World Health Organization (WHO).
The news of bubonic plague came after Chinese researchers issued an early warning over another potential pandemic caused by an influenza virus in pigs.
China says G4 swine flu virus not new; does not infect humans easily
That study, by a team of Chinese scientists and published by the U.S. journal Proceedings of the National Academy of Sciences (PNAS), warned that a new swine flu virus, named G4, has become more infectious to humans and could become a potential “pandemic virus.”However, China’s agriculture ministry said in a statement that the study has been interpreted by the media “in an exaggerated and nonfactual way.”
An analysis by the ministry concluded that sampling of the published study is too small to be representative, while the article lacks adequate evidence to show the G4 virus has become the dominant strain among pigs.